Summary
Biotech stocks are competing for space in the new highs list, as we commence the 2007 year. This may or may not have something to do with recent discovery of stem cells in the amniotic fluid of expectant mothers reminding traders that yes, the biotech sector is still a part of the Australian market, despite the oversold nature of their shares last year. Early signs of renewed investor interest her